sulfur hexafluoride has been researched along with Cardiomyopathies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeria, C; de Agustín, JA; Garcia-Fernandez, MA; Gomez de Diego, JJ; Luaces, M; Macaya, C; Marcos-Alberca, P; Nuñez-Gil, IJ; Perez de Isla, L; Rodrigo, JL | 1 |
| Häggström, J; Modler, P; Streitberger, A | 1 |
| Cosyns, B; Degaillier, C; Droogmans, S; Franken, PR; Garbar, C; Hernot, S; Lahoutte, T; Roosens, B; Schoors, D; Van Camp, G; Weytjens, C | 1 |
| Burden, L; Chelliah, RK; Hickman, M; Kinsey, C; Senior, R | 1 |
| Jia, XB; Sun, FR; Wang, XJ; Yao, GH; Zhang, MQ; Zhang, Y | 1 |
| Chandrasekaran, K; Hagen, ME; Khandheria, BK; Langins, AP; Miller, TD; Yip, GW | 1 |
| Cosyns, B; Daniels, C; Schoors, D; Van Camp, G; Vanderhoogstrate, M; Weytjens, C | 1 |
1 trial(s) available for sulfur hexafluoride and Cardiomyopathies
| Article | Year |
|---|---|
Feasibility of continuous venous infusion of SonoVue for qualitative assessment of reversible coronary perfusion defects in stress myocardial contrast echocardiography.
Topics: Aged; Aged, 80 and over; Cardiomyopathies; Chi-Square Distribution; Contrast Media; Coronary Circulation; Dipyridamole; Echocardiography, Stress; Feasibility Studies; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Phospholipids; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Sulfur Hexafluoride; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2003 |
6 other study(ies) available for sulfur hexafluoride and Cardiomyopathies
| Article | Year |
|---|---|
Subclinical systolic dysfunction in left ventricular non-compaction cardiomyopathy unmasked by contrast echocardiography.
Topics: Adult; Cardiomyopathies; Diagnosis, Differential; Echocardiography, Doppler, Color; Heart Ventricles; Humans; Male; Phospholipids; Sulfur Hexafluoride; Systole; Ventricular Dysfunction, Left | 2014 |
Increased normalized pulmonary transit times and pulmonary blood volumes in cardiomyopathic cats with or without congestive heart failure.
Topics: Animals; Blood Flow Velocity; Cardiomyopathies; Cat Diseases; Cats; Contrast Media; Female; Heart Failure; Male; Phospholipids; Pulmonary Circulation; Stroke Volume; Sulfur Hexafluoride | 2015 |
Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats.
Topics: Animals; Capillaries; Cardiomyopathies; Contrast Media; Coronary Circulation; Diabetes Mellitus, Experimental; Dipyridamole; Male; Myocardium; Observer Variation; Phospholipids; Rats; Rats, Wistar; Reproducibility of Results; Sulfur Hexafluoride; Time Factors; Ultrasonography; Ventricular Function, Left | 2008 |
Myocardial contrast echocardiography versus single photon emission computed tomography for assessment of hibernating myocardium in ischemic cardiomyopathy: preliminary qualitative and quantitative results.
Topics: Aged; Cardiomyopathies; Contrast Media; Echocardiography; Female; Humans; Male; Myocardial Stunning; Perfusion Imaging; Phospholipids; Pilot Projects; Reproducibility of Results; Sensitivity and Specificity; Sulfur Hexafluoride; Tomography, Emission-Computed, Single-Photon | 2010 |
Region of interest tracking in real-time myocardial contrast echocardiography.
Topics: Algorithms; Animals; Cardiomyopathies; Contrast Media; Disease Models, Animal; Echocardiography; Humans; Image Processing, Computer-Assisted; Microbubbles; Sulfur Hexafluoride | 2011 |
Tissue Doppler imaging does not show infraclinical alteration of myocardial function after contrast echocardiography.
Topics: Adult; Cardiomyopathies; Contrast Media; Echocardiography; Echocardiography, Doppler; Female; Humans; Male; Microbubbles; Middle Aged; Phospholipids; Prospective Studies; Safety; Sulfur Hexafluoride; Ventricular Function, Left | 2005 |